Trials / Active Not Recruiting
Active Not RecruitingNCT07186595
A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance
A Prospective, Open-Label Study to Evaluate Subject Satisfaction With Overall Facial Appearance After Treatment With JUVÉDERM® Products in Medical Weight Loss (MWL) Subjects
- Status
- Active Not Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 22 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of JUVÉDERM products in adults seeking improvement in facial volume and/or skin quality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | JUVÉDERM VOLUX XC | Injections |
| DEVICE | JUVÉDERM VOLUMA XC | Injections |
| DEVICE | JUVÉDERM VOLBELLA XC | Injections |
| DEVICE | JUVÉDERM VOLLURE XC | Injections |
| DEVICE | SKINVIVE by JUVÉDERM | Injections |
| DEVICE | JUVÉDERM ULTRA XC | Injections |
| DEVICE | JUVÉDERM ULTRA PLUS XC | Injections |
Timeline
- Start date
- 2025-09-25
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
- First posted
- 2025-09-22
- Last updated
- 2026-02-23
Locations
10 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07186595. Inclusion in this directory is not an endorsement.